Message Pharmaceuticals' Unattributed - III Round

Message Pharmaceuticals raised a round of funding on October 01, 2001.

Message Pharmaceuticals, Inc. is leveraging its platform technology in developing new classes of drugs that mimic RNA binding proteins to treat all major disease categories.…

Articles about Message Pharmaceuticals' Unattributed - III Round: